William A. Scott
Corporate Officer/Principal en The Rockefeller University .
Perfil
Dr. William A.
Scott has extensive research and management experience in both biotechnology and large pharmaceutical companies.
Bill was previously Chief Executive Officer of Physiome Sciences, Inc., a company whose mission is to help pharmaceutical companies develop better drugs faster through the use of biological simulations.
Prior to that, he held various senior level positions at Bristol-Myers Squibb (“BMS”) including Senior Vice President, Exploratory and Drug Discovery Research at BMS Pharmaceutical Research Institute from 1990 through 1996.
During this period, he oversaw the submission of over 70 new chemical entities for development as new therapeutic agents.
He consults or serves as a member of the board of directors of several biotechnology companies, including serving on the boards of publicly-traded AtheroGenics, Inc., Deltagen, Inc. and Variagenics, Inc. Bill holds a B.S.
in Chemistry from University of Illinois and a Ph.D.
in Biochemistry from the California Institute of Technology.
He is also an Adjunct Professor at the Rockefeller University, where he has been affiliated since 1969.
Cargos activos de William A. Scott
| Empresas | Cargo | Inicio |
|---|---|---|
| The Rockefeller University | Corporate Officer/Principal | 01/01/1969 |
KBL Healthcare Ventures
 KBL Healthcare Ventures Investment ManagersFinance KBL Healthcare Ventures (KBL Healthcare) is a venture capital firm founded in 1991 by Zachary C. Berk and Marlene R. Krauss. The firm is headquartered in New York. | Consultor / Asesor | - |
Antiguos cargos conocidos de William A. Scott.
| Empresas | Cargo | Fin |
|---|---|---|
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Director/Miembro de la Junta | 14/07/2009 |
Variagenics, Inc.
 Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Variagenics, Inc. develops molecular diagnostic tests by identifying genetic markers associated with response to cancer therapies, with the goal of optimizing patient care through both biopharmaceutical collaborations and its own internal research programs | Director/Miembro de la Junta | 15/11/2006 |
Physiome Sciences, Inc.
 Physiome Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Physiome Sciences, Inc. provides computer-based modeling and simulation of cells, and biological systems for drug development. The company was founded by Donna Rounds and is headquartered in Princeton, NJ. | Presidente | 01/01/1999 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 31/12/1996 |
CombiChem, Inc.
 CombiChem, Inc. Miscellaneous Commercial ServicesCommercial Services CombiChem, Inc. used to provide computational drug recovery services to accelerate the discovery process for new drugs and chemical compounds. The company was founded in 1994 and headquartered in San Diego, CA | Director/Miembro de la Junta | - |
Formación de William A. Scott.
| California Institute of Technology | Doctorate Degree |
| University of Illinois | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| DELTAGEN INC. | Commercial Services |
| Empresas privadas | 8 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology AtheroGenics is a pharmaceutical company focused on the discovery, development and commercialization of novel drugs for the treatment of chronic inflammatory diseases, such as atherosclerosis, asthma and arthritis. | Health Technology |
Targanta Therapeutics, Inc.
 Targanta Therapeutics, Inc. BiotechnologyHealth Technology Targanta Therapeutics, Inc. develops antibiotic drugs and other related products. It focuses on developing and commercializing novel antibacterial agents to address unmet medical needs in the hospital market. The company also develops antibacterial pro-drugs for the treatment and prevention of bone infections. Targanta Therapeutics was founded in May 2007 and is located in St. Laurent, Canada | Health Technology |
Avalon Pharmaceuticals, Inc.
 Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avalon Pharmaceuticals, Inc. was a biopharmaceutical company focused on the discovery, development and commercialization of cancer therapeutics. The company was founded in November 1999 and headquartered in Germantown, MD. | Health Technology |
Physiome Sciences, Inc.
Physiome Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Physiome Sciences, Inc. provides computer-based modeling and simulation of cells, and biological systems for drug development. The company was founded by Donna Rounds and is headquartered in Princeton, NJ. | Commercial Services |
Variagenics, Inc.
Variagenics, Inc. Miscellaneous Commercial ServicesCommercial Services Variagenics, Inc. develops molecular diagnostic tests by identifying genetic markers associated with response to cancer therapies, with the goal of optimizing patient care through both biopharmaceutical collaborations and its own internal research programs | Commercial Services |
VenGrowth Capital Partners, Inc.
 VenGrowth Capital Partners, Inc. Investment ManagersFinance Founded in 1982, VenGrowth Capital Partners, Inc. is a private equity and venture capital firm located in Toronto, Ontario. The firm is a subsidiary of Covington Capital Corp. They manage retail and institutional assets. | Finance |
CombiChem, Inc.
CombiChem, Inc. Miscellaneous Commercial ServicesCommercial Services CombiChem, Inc. used to provide computational drug recovery services to accelerate the discovery process for new drugs and chemical compounds. The company was founded in 1994 and headquartered in San Diego, CA | Commercial Services |
KBL Healthcare Ventures
KBL Healthcare Ventures Investment ManagersFinance KBL Healthcare Ventures (KBL Healthcare) is a venture capital firm founded in 1991 by Zachary C. Berk and Marlene R. Krauss. The firm is headquartered in New York. | Finance |
- Bolsa de valores
- Insiders
- William A. Scott
